Korea's Panagene Adds miRNA Array Lines for Cancer, Stem-Cell Research
August 11, 2009
Korea's Panagene Adds miRNA Array Lines for Cancer, Stem-Cell Research
Marketing director Dalsoo Kim said the company now sells a PANArray miRNA expression-profiling kit for surveying stem cell-related miRNAs. The launch follows its debut in June of a kit for profiling cancer-related miRNAs.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Rosetta Genomics Looking Beyond Cancer to Cardio, Neuro, Women's Health for Blood-Based MDx Program
June 11, 2013 / BioArray News - Though Affy's MicroRNA Genotyping Chips Don't Inspire Rival Offerings, Firms Say Market is Still Dynamic
December 4, 2012 / BioArray News - Falcon Genomics Showcases Cancer Biochip in Breast Cancer Studies; Plans Next-Gen System
October 2, 2012 / BioArray News - Plexpress, Phalanx Partner to Offer Gene Expression Service
June 28, 2012 / GenomeWeb Daily News - IP Update: Columbia University; Affymetrix; Cold Spring Harbor Laboratory; Merck; and More
March 13, 2012 / BioArray News